Search for: "The Regulatory Review" Results 9961 - 9980 of 28,283
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Feb 2019, 10:13 am by Scott H. Kimpel
’” After reviewing new evidence, the judge subsequently reversed his position and found that Blockvest had indeed issued a security. [read post]
23 Aug 2022, 7:58 pm by Kurt R. Karst
The NIH RADx-sponsored study mentioned in the safety communication addresses a data gap in FDA’s review of antigen tests. [read post]
This past week, several consumer protection and regulatory actions made headlines: Mars Petcare Settles With the FTC Over False Advertising Claims Mars Petcare U.S., Inc., (“Mars Petcare”) has agreed to settle FTC allegations that the company falsely advertised its Eukanuba dog food. [read post]
CARU Recommends Spiral Toys Modify Ads Spiral Toys, which manufactures Cloud Pets plush toys with an accompanying Cloud Pet mobile app, agreed to modify its TV ads to clearly disclose that batteries are not included with the advertised toy, and to modify its privacy practices at the request of the Children’s Advertising Review Unit (“CARU”). [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US:… [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US:… [read post]
27 Jun 2020, 12:43 pm by David Oxenford and Adam Sandler
(Order) The FCC denied an Application for Review submitted by a West Virginia LPTV operator making clear that the Communications Act and FCC rules do not require mandatory carriage of LPTV stations on satellite television systems. [read post]
9 Jan 2022, 8:32 am by David Oxenford and Adam Sandler
The terms of the settlement have not been disclosed, but commercial stations represented by RMLC should have received a proposed license agreement to review. [read post]
12 Jun 2022, 8:52 am by David Oxenford
State EAS committees should review and update their plans as required by these new rules (Public Notice). [read post]
24 Apr 2022, 9:12 am by David Oxenford and Adam Sandler
Here are some of the regulatory developments of significance to broadcasters from the last week, with links to where you can go to find more information as to how these actions may affect your operations. [read post]
27 Feb 2022, 8:26 am by David Oxenford and Adam Sandler
  Even though the stay was denied, the new rules are not yet effective while undergoing a Paperwork Reduction Act review. [read post]
15 Feb 2022, 6:39 am by Cristina Mariottini
Carlos Santaló Goris, Researcher at the Max Planck Institute Luxembourg for International, European and Regulatory Procedural Law and Ph.D. candidate at the University of Luxembourg, offers an analysis of the Spanish statistics on the European Small Claims Procedure. [read post]
10 Jul 2012, 9:52 am by Paul Maharg
 Very interesting feedback on the three regulatory models from my small group which included great international lawyers & educators such as Alan Treleaven, Paul Woods Afternoon keynote was Susskind on how we can train 21st century lawyers. [read post]
8 Feb 2011, 12:33 pm by emp
One hospital provides a unique set of facts that raises the question of appropriate regulatory responses. [read post]
20 Mar 2022, 8:45 am by David Oxenford and Adam Sandler
  Stations have six months to review existing contracts for the sale of program time to determine if there is foreign-government involvement and to come into compliance with the disclosure requirements. [read post]
15 Aug 2021, 6:37 am by David Oxenford and Adam Sandler
Here are some of the regulatory developments of significance to broadcasters from the last week, with links to where you can go to find more information as to how these actions may affect your operations. [read post]
18 Dec 2013, 6:01 am by Adam Weinstein
 In addition, FINRA also found that the MMM note transactions had not been reviewed or approved by HFP’s investment committee. [read post]